Skip to content

Clinicopathological and Physiological Analysis of Intracholecystic Papillary Neoplasms

Clinicopathological and Physiological Analysis of Intracholecystic Papillary Neoplasms: A nationwide project study of Japanese society of Hepato-Biliary-Pancreatic Surgery - Clinicopathological and Physiological Analysis of Intracholecystic Papillary Neoplasms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057702
Enrollment
345
Registered
2025-04-24
Start date
2025-04-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracholecystic papillary neoplasm

Interventions

None listed

Sponsors

Ibaraki Medical Center, Tokyo Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Patients who underwent surgical resection and were diagnosed with ICPN based on the 5th edition of the WHO Classification of Tumors of the Digestive System at each participating institution. 2 Patients with available pathological slides diagnosed as ICPN.

Exclusion criteria

Exclusion criteria: 1 In cases where there were doubts regarding the submitted pathological data, a central pathological review was conducted by the Department of Investigative Pathology, Tohoku University Graduate School of Medicine. Patients who were ultimately not diagnosed with ICPN based on this final pathological assessment were excluded from the study. For excluded patients, the participating institution was informed of the reason when the pathological slides were returned, and relevant information was provided. The collected data for such patients were deleted by the principal investigator. 2 Patients who expressed a desire not to participate in the study.

Design outcomes

Primary

MeasureTime frame
Overall Survival by Subgroups Stratified According to WHO Histopathological Classification

Secondary

MeasureTime frame
1 Comparison Between Subgroups Stratified by WHO Histopathological Classification and Clinical Background 2 Analysis of Preoperative Clinicophysiological Factors in Subgroups Stratified by WHO Classification 3 Progression-Free Survival in Subgroups Stratified by WHO Histopathological Classification 4 Comparative Analysis of WHO Classification With TNM Staging and the Japanese Classification of Biliary Tract Cancers 5 Investigation of Prognostic Factors Based on Preoperative Clinicophysiological and Pathological Findings in ICPN 6 Association of Background, Clinicophysiological Factors, and Prognosis With Subgroups Stratified by Each Histopathological Diagnosis

Countries

Japan

Contacts

Public ContactRyoichi Miyamoto

Ibaraki Medical Center, Tokyo Medical University Department of Gastroenterological Surgery

ssuzuki@tokyo-med.ac.jp029-887-1161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026